Anhui Huaheng Biotechnology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000052M6
CNY
15.40
-1.72 (-10.05%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
771.26
668.30
704.38
802.10
687.06
638.91
522.81
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
771.26
668.30
704.38
802.10
687.06
638.91
522.81
Raw Material Cost
609.59
590.06
560.56
620.42
530.32
537.01
418.94
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
12.58
2.92
20.47
7.91
12.54
10.75
10.53
Selling and Distribution Expenses
68.01
72.33
45.48
64.01
67.70
59.13
54.05
Other Expenses
2.24
3.74
1.38
2.20
1.65
1.94
1.33
Total Expenditure (Excl Depreciation)
712.60
702.66
640.30
714.37
627.04
626.32
496.80
Operating Profit (PBDIT) excl Other Income
58.7
-34.4
64.1
87.69999999999999
60
12.6
26
Other Income
-4.98
1.43
11.77
0.35
10.42
22.93
6.67
Operating Profit (PBDIT)
48.77
19.76
135.72
121.66
115.09
65.24
65.13
Interest
12.58
2.92
20.47
7.91
12.54
10.75
10.53
Exceptional Items
-0.15
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
161.68
78.24
143.82
181.68
156.74
101.89
103.87
Depreciation
0.00
62.42
62.42
48.10
48.10
37.01
36.07
Profit Before Tax
36.04
-45.59
52.83
65.66
54.45
17.48
18.52
Tax
-1.62
-10.21
2.48
3.88
5.54
0.73
-0.39
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
42.10
-35.21
52.73
63.80
51.10
19.63
20.19
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
42.10
-35.21
52.73
63.80
51.10
19.63
20.19
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-4.57
-0.35
-2.45
-3.79
-1.96
-3.06
-0.18
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
37.53
-35.56
50.28
60.01
49.14
16.56
20.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,688.25
2,646.68
2,682.17
2,629.62
2,616.58
2,564.65
1,858.59
Earnings per share (EPS)
0.17
-0.14
0.21
0.26
0.21
0.08
0.09
Diluted Earnings per share
0.17
-0.14
0.21
0.26
0.21
0.08
0.09
Operating Profit Margin (Excl OI)
6.97%
-6.6%
8.73%
9.13%
8.23%
0.83%
4.28%
Gross Profit Margin
4.67%
2.52%
16.36%
14.18%
14.93%
8.53%
10.44%
PAT Margin
5.46%
-5.27%
7.49%
7.95%
7.44%
3.07%
3.86%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 12.25% vs 37.20% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is -23.63% vs -42.84% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -48.71% vs -18.33% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 0.80% vs 68.92% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of Anhui Huaheng Biotechnology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
771.26
0
771.26
Other Operating Income
0.00
0.00
0.00
Total Operating income
771.26
0
771.26
Raw Material Cost
609.59
0
609.59
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
12.58
0
12.58
Selling and Distribution Expenses
68.01
0
68.01
Other Expenses
2.24
0.00
2.24
Total Expenditure (Excl Depreciation)
712.60
0
712.60
Operating Profit (PBDIT) excl Other Income
58.66
0.00
58.66
Other Income
-4.98
0
-4.98
Operating Profit (PBDIT)
48.77
0
48.77
Interest
12.58
0
12.58
Exceptional Items
-0.15
0
-0.15
Gross Profit (PBDT)
161.68
0
161.68
Depreciation
0.00
0
0.00
Profit Before Tax
36.04
0
36.04
Tax
-1.62
0
-1.62
Provisions and contingencies
0
0
0.00
Profit After Tax
42.10
0
42.10
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
42.10
0
42.10
Share in Profit of Associates
0
0
0.00
Minority Interest
-4.57
0
-4.57
Other related items
0.00
0.00
0.00
Consolidated Net Profit
37.53
0
37.53
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,688.25
0
2,688.25
Earnings per share (EPS)
0.17
0
0.17
Diluted Earnings per share
0.17
0
0.17
Operating Profit Margin (Excl OI)
6.97%
0%
0.00
6.97%
Gross Profit Margin
4.67%
0%
0.00
4.67%
PAT Margin
5.46%
0%
0.00
5.46%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 77.13 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 15.41% vs -5.12% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 12.25% vs 37.20% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.75 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 205.34% vs -170.78% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -23.63% vs -42.84% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.37 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 193.44% vs -85.24% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -48.71% vs -18.33% in Mar 2025

Quarterly - Interest
Interest 1.26 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 334.48% vs -85.85% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 0.80% vs 68.92% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.97%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025